Moleculin Biotech OverviewMoleculin Biotech EBIT
EBIT (Earnings Before Interest and Taxes) analysis for MBRX.
Quarterly EBIT
-$7.87M
↓ 32.49% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$7.54M
↑ 70.89% YoY
Trailing 12 months ending Mar 31, 2026
Moleculin Biotech OverviewEBIT (Earnings Before Interest and Taxes) analysis for MBRX.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026